Cystic Fibrosis Market is Forecast to Show Positive Growth until 2017

a new report on "Cystic Fibrosis - Pipeline Assessment and Market Forecasts to 2017" which gives the competitive landscape and companies focus on Cystic Fibrosis market.

Online PR News – 09-August-2010 – – Cystic Fibrosis - Pipeline Assessment and Market Forecasts to 2017

The report identifies the key trends shaping and driving the global cystic fibrosis market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shifts in the positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global cystic fibrosis sector. ( )

The Cystic Fibrosis Market is Forecast to Show Positive Growth until 2017
It estimates that the Cystic Fibrosis (CF) market was worth $1,143m in 2009 and projects it to grow a Compound Annual Growth Rate (CAGR) of 8.2% until 2017, when it will exceed $2,140m. The market is forecast to grow due to the introduction of novel therapies. The current market has four Food and Drug Administration (FDA) approved branded products for the treatment of CF and there are many opportunities in the market for new entrants which have novel mechanisms of actions. The CF market has a high unmet need, which is driven by moderately satisfied patients.

Major Companies Focus on Cystic Fibrosis Drug Development Landscape
Novartis AG and Genentech are the leading competitors in the global CF market. Together, these companies accounted for approximately 87% of the global market in 2009. Genentech remained the market leader with a share of approximately 44%. However, Cystic Fibrosis Foundation Therapeutics (CFFT) and companies such as Gilead Sciences, Vertex Pharma, Pharmaxis and Pari Pharma, with some of the most technologically advanced products in their pipeline portfolios, are expected to attract the majority of investors’ attention.

For more information kindly visit :

Related Reports

Cystic Fibrosis Therapy Area Pipeline Report

Stakeholder Opinions Cystic Fibrosis A pipeline full of hope


Contact us at :

Global Knowledge Research Centre
Tel: +91 22 27578668
Fax: +91 22 27579131